Ted W Love - Net Worth and Insider Trading

Ted W Love Net Worth

The estimated net worth of Ted W Love is at least $71 Million dollars as of 2025-04-28. Ted W Love is the See Remarks of Global Blood Therapeutics Inc and owns about 1,037,133 shares of Global Blood Therapeutics Inc (GBT) stock worth over $71 Million. Ted W Love is also the Director of Cascadian Therapeutics Inc and owns about 27,209 shares of Cascadian Therapeutics Inc (CASC) stock worth over $272,634. Details can be seen in Ted W Love's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ted W Love has not made any transactions after 2020-04-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Ted W Love

Ted W Love Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Ted W Love owns 12 companies in total, including Seagen Inc (SGEN) , Royalty Pharma PLC (RPRX) , and Global Blood Therapeutics Inc (GBT) among others .

Click here to see the complete history of Ted W Love’s form 4 insider trades.

Insider Ownership Summary of Ted W Love

Ticker	Company	Transaction Date	Type of Owner
SGEN	Seagen Inc	2022-05-13	director
RPRX	Royalty Pharma PLC	2022-06-24	director
GBT	Global Blood Therapeutics Inc	2020-04-28	director & See Remarks
		2020-07-02	director
		2012-06-13	director
		2018-03-09	director
		2012-08-10	director
		2012-09-05	director
		2012-06-13	director
		2010-03-24	director
		2004-05-07	President and C.E.O.
		2023-08-03	director

Ted W Love Latest Holdings Summary

Ted W Love currently owns a total of 2 stocks. Among these stocks, Ted W Love owns 1,037,133 shares of Global Blood Therapeutics Inc (GBT) as of April 28, 2020, with a value of $71 Million and a weighting of 99.62%. Ted W Love also owns 27,209 shares of Cascadian Therapeutics Inc (CASC) as of February 2, 2017, with a value of $272,634 and a weighting of 0.38%.

Latest Holdings of Ted W Love

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
GBT	Global Blood Therapeutics Inc	2020-04-28	1,037,133	68.49	71,033,239
CASC	Cascadian Therapeutics Inc	2017-02-02	27,209	10.02	272,634

Holding Weightings of Ted W Love

Ted W Love Form 4 Trading Tracker

According to the SEC Form 4 filings, Ted W Love has made a total of 0 transactions in Global Blood Therapeutics Inc (GBT) over the past 5 years. The most-recent trade in Global Blood Therapeutics Inc is the sale of 42,817 shares on April 28, 2020, which brought Ted W Love around $3 Million.

According to the SEC Form 4 filings, Ted W Love has made a total of 0 transactions in Cascadian Therapeutics Inc (CASC) over the past 5 years. The most-recent trade in Cascadian Therapeutics Inc is the acquisition of 23,000 shares on February 2, 2017, which cost Ted W Love around $97,520.

Insider Trading History of Ted W Love

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Ted W Love Trading Performance

GuruFocus tracks the stock performance after each of Ted W Love's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ted W Love is -7.93%. GuruFocus also compares Ted W Love's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ted W Love within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Ted W Love's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Ted W Love

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-2.39
Relative Return to S&P 500(%)	-1.94

Ted W Love Ownership Network

Ownership Network List of Ted W Love

No Data

Ownership Network Relation of Ted W Love

Ted W Love Owned Company Details

What does Seagen Inc do?

Who are the key executives at Seagen Inc?

Ted W Love is the director of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .

Seagen Inc (SGEN) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 10,620 shares made by David R Epstein , and a net sale of 8,785 shares made by Vaughn B Himes .

In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,405 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,405 shares.

Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seagen Inc Insider Transactions

No Available Data

What does Royalty Pharma PLC do?

Who are the key executives at Royalty Pharma PLC?

Ted W Love is the director of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , EVP & CFO Terrance P. Coyne , and director & CEO & Chairman of the Board Pablo G. Legorreta .

Royalty Pharma PLC (RPRX) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in Royalty Pharma PLC (RPRX). Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 934,197 shares made by Avara Management Ltd , and a net sale of 470,000 shares made by Rory B Riggs .

In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,404,197 shares of Royalty Pharma PLC (RPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,404,197 shares.

Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Royalty Pharma PLC Insider Transactions

No Available Data

What does Global Blood Therapeutics Inc do?

Who are the key executives at Global Blood Therapeutics Inc?

Ted W Love is the director & See Remarks of Global Blood Therapeutics Inc. Other key executives at Global Blood Therapeutics Inc include Chief Financial Officer Jeffrey S Farrow , See Remarks Nazila Habibizad , and Chief Human Resources Officer Carrie Krehlik .

Global Blood Therapeutics Inc (GBT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Global Blood Therapeutics Inc Insider Transactions

No Available Data

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Ted W Love is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Ted W Love is the director of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 150,869 shares made by Bradley L Campbell , a net sale of 266,751 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 400 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 400 shares. During the past 18 months, 618,495 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 618,495 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Ted W Love is the director of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

Ted W Love is the director of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Savara Inc do?

Who are the key executives at Savara Inc?

Ted W Love is the director of Savara Inc. Other key executives at Savara Inc include Chief Financial Officer David L Lowrance , 10 percent owner Rick Yang , and 10 percent owner Forest Baskett .

Savara Inc (SVRA) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 250,000 shares made by David A Ramsay , a net sale of 138,702 shares made by Matthew Pauls , and a net sale of 35,000 shares made by David L Lowrance .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 150,000 shares, with a net purchase of 150,000 shares. During the past 18 months, 275,545 shares of Savara Inc (SVRA) were sold and 270,000 shares were bought by its insiders, resulting in a net sale of 5,545 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Savara Inc Insider Transactions

No Available Data

What does Affymax Inc do?

Who are the key executives at Affymax Inc?

Ted W Love is the director of Affymax Inc. Other key executives at Affymax Inc include Chief Financial Officer Mark G Thompson , Chief Commercial Officer Jeffrey H Knapp , and Chief Financial Officer Herb Cross .

Affymax Inc (AFFY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Affymax Inc (AFFY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Affymax Inc (AFFY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Affymax Inc (AFFY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Affymax Inc Insider Transactions

No Available Data

What does Bio-Rad Laboratories Inc do?

Who are the key executives at Bio-Rad Laboratories Inc?

Ted W Love is the director of Bio-Rad Laboratories Inc. Other key executives at Bio-Rad Laboratories Inc include INT PRIN ACCTG OFC Tania Devilliers , EVP & Global Supply Chain Sedat Evran , and EVP & Global Human Resources Corey Colleen .

Bio-Rad Laboratories Inc (BIO) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in Bio-Rad Laboratories Inc (BIO). Other recent insider transactions involving Bio-Rad Laboratories Inc (BIO) include a net sale of 7,011 shares made by Michael Crowley , a net sale of 3,000 shares made by Andrew J. Last , and a net sale of 2,500 shares made by Timothy S Ernst .

In summary, during the past 3 months, insiders sold 3,000 shares of Bio-Rad Laboratories Inc (BIO) in total and bought 0 shares, with a net sale of 3,000 shares. During the past 18 months, 14,334 shares of Bio-Rad Laboratories Inc (BIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,334 shares.

Bio-Rad Laboratories Inc (BIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bio-Rad Laboratories Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Ted W Love is the President and C.E.O. of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Ted W Love made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Structure Therapeutics Inc do?

Who are the key executives at Structure Therapeutics Inc?

Ted W Love is the director of Structure Therapeutics Inc. Other key executives at Structure Therapeutics Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Gp Holdings Llc , and other: See Explanation of Responses Bvf Ii Gp Llc .

Structure Therapeutics Inc (GPCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc (GPCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc (GPCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Structure Therapeutics Inc (GPCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Structure Therapeutics Inc Insider Transactions

No Available Data

Ted W Love Mailing Address

Above is the net worth, insider trading, and ownership report for Ted W Love. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ted W Love's mailing address is: South San Francisco Ca 94080.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.